Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Rheumatoid Arthritis

  Free Subscription


05.08.2019

5 Ann Rheum Dis
7 Clin Exp Rheumatol
6 Clin Rheumatol
1 Curr Opin Rheumatol
2 Intern Med
2 J Rheumatol
1 Rheumatol Int
1 Z Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. RODRIGUEZ-UBREVA J, de la Calle-Fabregat C, Li T, Ciudad L, et al
    Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis.
    Ann Rheum Dis. 2019 Aug 1. pii: annrheumdis-2019-215355.
    PubMed     Text format     Abstract available

  2. WALLACE BI, Wallace DM, Waljee AK, Clauw DJ, et al
    Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking.
    Ann Rheum Dis. 2019 Jul 31. pii: annrheumdis-2019-216009.
    PubMed     Text format    

  3. FLEISCHMANN RM, Genovese MC, Enejosa JV, Mysler E, et al
    Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response.
    Ann Rheum Dis. 2019 Jul 30. pii: annrheumdis-2019-215764.
    PubMed     Text format     Abstract available

  4. TANAKA Y, Takeuchi T, Tanaka S, Kawakami A, et al
    Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3).
    Ann Rheum Dis. 2019 Jul 26. pii: annrheumdis-2019-215163.
    PubMed     Text format     Abstract available

  5. TAKEUCHI T, Tanaka Y, Tanaka S, Kawakami A, et al
    Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan.
    Ann Rheum Dis. 2019 Jul 26. pii: annrheumdis-2019-215164.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  6. BERTHELOT JM, Bart G, Darrieutort-Lafitte C, Le Goff B, et al
    Pain catastrophising worsens RAPID3 in all rheumatologic conditions.
    Clin Exp Rheumatol. 2019;37:600-607.
    PubMed     Text format     Abstract available

  7. LOPEZ J, Merino L, Piris L, Herrera FS, et al
    Rituximab induces a lasting, non-cumulative remodelling of the B-cell compartment.
    Clin Exp Rheumatol. 2019;37:615-622.
    PubMed     Text format     Abstract available

  8. SILVA CFR, Duarte C, Ferreira RJO, Santos E, et al
    Depression, disability and sleep disturbance are the main explanatory factors of fatigue in rheumatoid arthritis: a path analysis model.
    Clin Exp Rheumatol. 2019 Jul 19. pii: 13806.
    PubMed     Text format     Abstract available

  9. DORIA A, Zavaglia D
    Monotherapy is a relevant option in rheumatoid arthritis treatment: a literature review.
    Clin Exp Rheumatol. 2019 Jul 22. pii: 13054.
    PubMed     Text format     Abstract available

  10. PETRACKOVA A, Horak P, Radvansky M, Fillerova R, et al
    Revealed heterogeneity in rheumatoid arthritis based on multivariate innate signature analysis.
    Clin Exp Rheumatol. 2019 Aug 3. pii: 14171.
    PubMed     Text format     Abstract available

  11. LI Z, Niu H, Yao H, Chen M, et al
    IL-17A upregulates P-glycoprotein expression in peripheral blood lymphocytes of patients with rheumatoid arthritis through TAK1.
    Clin Exp Rheumatol. 2019 Jul 19. pii: 13728.
    PubMed     Text format     Abstract available

  12. ZABOTTI A, Finzel S, Baraliakos X, Aouad K, et al
    Imaging in the preclinical phases of rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Jul 25. pii: 14199.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  13. GADEHOLT O, Hausotter K, Eberle H, Klink T, et al
    Correction to: Differing X-ray patterns in seronegative and seropositive rheumatoid arthritis.
    Clin Rheumatol. 2019 Jul 26. pii: 10.1007/s10067-019-04703.
    PubMed     Text format     Abstract available

  14. MOHARAMOGHLI M, Hassan-Zadeh V, Dolatshahi E, Alizadeh Z, et al
    The expression of GAS5, THRIL, and RMRP lncRNAs is increased in T cells of patients with rheumatoid arthritis.
    Clin Rheumatol. 2019 Jul 25. pii: 10.1007/s10067-019-04694.
    PubMed     Text format     Abstract available

  15. SHADICK NA, Gerlanc NM, Frits ML, Stolshek BS, et al
    The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
    Clin Rheumatol. 2019 Jul 29. pii: 10.1007/s10067-019-04649.
    PubMed     Text format     Abstract available

  16. TAVAKOLPOUR S, Alesaeidi S, Darvishi M, GhasemiAdl M, et al
    A comprehensive review of rituximab therapy in rheumatoid arthritis patients.
    Clin Rheumatol. 2019 Aug 1. pii: 10.1007/s10067-019-04699.
    PubMed     Text format     Abstract available

  17. YOSHII I, Chijiwa T, Sawada N
    Validity of adopting a Health Assessment Questionnaire Disability Index less than 0.5 as a target in elderly rheumatoid arthritis patients.
    Clin Rheumatol. 2019 Aug 1. pii: 10.1007/s10067-019-04692.
    PubMed     Text format     Abstract available

  18. ZAFARI P, Zarifian A, Alizadeh-Navaei R, Taghadosi M, et al
    Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: a systematic review and meta-analysis of case-control studies.
    Clin Rheumatol. 2019 Aug 3. pii: 10.1007/s10067-019-04713.
    PubMed     Text format     Abstract available


    Curr Opin Rheumatol

  19. LUCCHESE A
    Periodontal bacteria and the rheumatoid arthritis-related antigen RA-A47: the cross-reactivity potential.
    Curr Opin Rheumatol. 2019;31:542-545.
    PubMed     Text format     Abstract available


    Intern Med

  20. ISSHIKI T, Matsuyama H, Sakamoto S, Honma N, et al
    Development of Propionibacterium acnes-associated Sarcoidosis During Etanercept Therapy.
    Intern Med. 2019;58:1473-1477.
    PubMed     Text format     Abstract available

  21. NISHIGORI R, Warabi Y, Shishido-Hara Y, Nakamichi K, et al
    Inflammatory Cerebellar PML with a CD4/CD8 ratio of 2.9 Showed a Favorable Prognosis in a Patient with Rheumatoid Arthritis: A Case Report.
    Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.3038.
    PubMed     Text format     Abstract available


    J Rheumatol

  22. HARROLD LR, Griffith J, Zueger P, Litman HJ, et al
    Long-term, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-Based Registry.
    J Rheumatol. 2019 Aug 1. pii: jrheum.190260. doi: 10.3899/jrheum.190260.
    PubMed     Text format     Abstract available

  23. CASTELLANOS-MOREIRA R, Rodriguez-Garcia SC, Gomez-Puerta JA, Ruiz-Esquide V, et al
    Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype?
    J Rheumatol. 2019 Aug 1. pii: jrheum.190061. doi: 10.3899/jrheum.190061.
    PubMed     Text format     Abstract available


    Rheumatol Int

  24. YANG Y, Wang Z, Fu Z, Yang R, et al
    Stiffening of aorta is more preferentially associated with rheumatoid arthritis than peripheral arteries.
    Rheumatol Int. 2019 Aug 2. pii: 10.1007/s00296-019-04405.
    PubMed     Text format     Abstract available


    Z Rheumatol

  25. SCHLIEKER R, Keysser G
    [Establishment of the current classification criteria for axial spondylarthritis, rheumatoid arthritis and SLE in routine practice of German rheumatologists].
    Z Rheumatol. 2019 Jul 25. pii: 10.1007/s00393-019-0677.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: